Capstone Investment Advisors’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.24M | Buy |
7,600
+1,400
| +23% | +$416K | ﹤0.01% | 612 |
|
|
2025
Q4 | $1.69M | Sell |
6,200
-3,100
| -33% | -$842K | ﹤0.01% | 676 |
|
|
2025
Q3 | $2.51M | Sell |
9,300
-500
| -5% | -$136K | ﹤0.01% | 688 |
|
|
2025
Q2 | $2.7M | Sell |
9,800
-4,300
| -30% | -$1.17M | 0.01% | 546 |
|
|
2025
Q1 | $3.74M | Sell |
14,100
-9,900
| -41% | -$2.44M | 0.01% | 527 |
|
|
2024
Q4 | $5.57M | Buy |
24,000
+9,100
| +61% | +$2.09M | 0.01% | 511 |
|
|
2024
Q3 | $3.29M | Buy |
14,900
+2,500
| +20% | +$517K | 0.01% | 574 |
|
|
2024
Q2 | $2.44M | Buy |
12,400
+1,400
| +13% | +$289K | 0.01% | 653 |
|
|
2024
Q1 | $2.37M | Sell |
11,000
-8,900
| -45% | -$1.87M | 0.01% | 714 |
|
|
2023
Q4 | $4.19M | Buy |
19,900
+11,800
| +146% | +$2.52M | 0.01% | 594 |
|
|
2023
Q3 | $1.62M | Buy |
8,100
+500
| +7% | +$99.4K | 0.01% | 800 |
|
|
2023
Q2 | $1.41M | Buy |
7,600
+800
| +12% | +$148K | 0.01% | 749 |
|
|
2023
Q1 | $1.3M | Sell |
6,800
-18,800
| -73% | -$3.4M | 0.01% | 716 |
|
|
2022
Q4 | $4.3M | Buy |
25,600
+1,800
| +8% | +$313K | 0.03% | 431 |
|
|
2022
Q3 | $4.22M | Sell |
23,800
-1,500
| -6% | -$296K | 0.03% | 455 |
|
|
2022
Q2 | $5.18M | Sell |
25,300
-50,400
| -67% | -$10.7M | 0.03% | 408 |
|
|
2022
Q1 | $18M | Buy |
75,700
+15,800
| +26% | +$3.71M | 0.05% | 289 |
|
|
2021
Q4 | $13.7M | Sell |
59,900
-19,400
| -24% | -$4.27M | 0.02% | 517 |
|
|
2021
Q3 | $15.3M | Buy |
79,300
+5,700
| +8% | +$1.15M | 0.03% | 489 |
|
|
2021
Q2 | $15.7M | Buy |
73,600
+14,000
| +23% | +$2.96M | 0.04% | 409 |
|
|
2021
Q1 | $12.2M | Sell |
59,600
-900
| -1% | -$177K | 0.04% | 420 |
|
|
2020
Q4 | $11M | Buy |
60,500
+5,400
| +10% | +$918K | 0.04% | 378 |
|
|
2020
Q3 | $9.22M | Buy |
55,100
+12,000
| +28% | +$2.02M | 0.05% | 349 |
|
|
2020
Q2 | $7M | Buy |
43,100
+1,900
| +5% | +$341K | 0.05% | 339 |
|
|
2020
Q1 | $7.12M | Buy |
41,200
+4,600
| +13% | +$916K | 0.11% | 190 |
|
|
2019
Q4 | $7.35M | Sell |
36,600
-6,700
| -15% | -$1.37M | 0.04% | 437 |
|
|
2019
Q3 | $9.15M | Buy |
43,300
+15,100
| +54% | +$3.16M | 0.06% | 302 |
|
|
2019
Q2 | $5.47M | Buy |
28,200
+13,500
| +92% | +$2.49M | 0.04% | 434 |
|
|
2019
Q1 | $2.42M | Buy |
14,700
+8,500
| +137% | +$1.5M | 0.02% | 537 |
|
|
2018
Q4 | $1.17M | Buy |
6,200
+2,700
| +77% | +$499K | 0.01% | 560 |
|
|
2018
Q3 | $596K | Buy |
3,500
+3,000
| +600% | +$505K | 0.01% | 749 |
|
|
2018
Q2 | $82K | Buy |
+500
| New | +$81.7K | ﹤0.01% | 631 |
|
Other funds holding CME
VCM
VPM
Capstone Investment Advisors's CME Position: Q1 2026 in Review
Capstone Investment Advisors increased its CME Group (CME) stake by 1% in Q1 2026, buying an estimated $184K and bringing the position to 60,620 shares worth $17.9M. The position accounts for 0.03% of the portfolio, ranked #192.
Capstone Investment Advisors first reported a position in CME in Q1 2016 and has held it in 25 quarters since. 1,793 funds tracked by Wall St. Rank hold CME as of Q1 2026.
- Capstone Investment Advisors held 60,620 shares of CME Group worth $17.9M as of Q1 2026.
- Capstone Investment Advisors bought 620 CME Group shares in Q1 2026, an estimated $184K.
- CME Group made up 0.03% of Capstone Investment Advisors's portfolio in Q1 2026, its #192 holding.
- Capstone Investment Advisors first reported a position in CME Group in Q1 2016 and has held it in 25 quarters since.
- 1,793 funds tracked by Wall St. Rank held CME Group as of Q1 2026.
Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.